ArticleInternational journal of ophthalmology2026
Comparison between Ahmed glaucoma valve implant and Keiki Mehta body pressure glaucoma implant in neovascular glaucoma: 24-month results.
Article in International journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo compare the 24-month clinical results of the Keiki Mehta body pressure (BP) glaucoma implants (KMI) versus the Ahmed glaucoma valve implants (AGVI; FP-7Model) in neovascular glaucoma (NVG).
methodsPatients with NVG and uncontrolled intraocular pressure (IOP) exceeding 21 mm Hg despite maximum-tolerated antiglaucoma medications were included in this retrospective study and treated with either KMI, or AGVI. Preoperative and postoperative IOP (at the 1d, 1, 3, 6, 12, and 24mo), number of glaucoma medications needed, success rate, postoperative complications, and visual acuity were evaluated.
resultsThe study enrolled 41 patients, comprising 19 (11 males) in the KMI group (mean age: 58.8±10.6y) and 22 (11 males) in the AGVI group (mean age: 60.2±16.8y). Preoperative IOP was similar between the groups (
conclusionKMI may be an alternative to AGVI in the management of NVG. To the best of our knowledge, this study is the first to compare the results of AGVI versus KMI for the treatment of NVG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.